Back to Search
Start Over
The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials.
- Source :
-
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Mar 01; Vol. 201 (5), pp. 511-513. - Publication Year :
- 2020
- Subjects :
- Humans
Latent Tuberculosis
Subjects
Details
- Language :
- English
- ISSN :
- 1535-4970
- Volume :
- 201
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- American journal of respiratory and critical care medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 31816247
- Full Text :
- https://doi.org/10.1164/rccm.201911-2258ED